⚠️ Deadline has passed: January 30, 2025

grantNational Science Foundation

Leveraging Innovations From Evolution (LIFE): Should You Apply?

Quick Facts

Funding

$1,000,000 to $1,200,000

Deadline

January 30, 2025

Regions

north_america

Domains

health, tech, general

Who This Is For

This opportunity is explicitly designed for established research teams within US-accredited Institutions of Higher Education who are poised to redefine the intersection of fundamental biology and technological application.

If your laboratory or a consortium of labs possesses deep expertise in both evolutionary *and* molecular biology, and you have a clear, innovative vision for translating these insights into novel biotech applications, you are a prime candidate.

The National Science Foundation (NSF) is seeking 'bold, integrative research' that doesn't just advance foundational knowledge but articulates a compelling pathway to real-world impact.

Crucially, your proposed work *must* leverage emerging AI and computational methods as a core component, demonstrating a sophisticated understanding of how these tools accelerate discovery and application.

Geographically, only US-based IHEs (including territories and Puerto Rico) are eligible, making this a focused call for domestic academic leadership in this burgeoning field.

Think interdisciplinary, high-impact, and translational, with a strong computational backbone.

Who Should NOT Apply

If your primary research focus is purely theoretical biology without a clear, demonstrable biotech application pathway, or if your work lacks robust integration of *both* evolutionary and molecular biology, this program is not for you.

This is definitively *not* for individual startups, private companies, or any entity not affiliated with a US-accredited Institution of Higher Education.

International institutions without a US campus lead are also ineligible. Projects that do not prominently feature and integrate AI and computational methods as a core leverage point will be considered a poor fit; simply adding AI as an afterthought will not suffice.

Similarly, if your proposed research is incremental rather than 'bold' and 'integrative,' or if you struggle to articulate a vision for translating your findings into biotech, save your valuable time.

This grant is highly specific, so avoid applying if your project doesn't hit all these targeted interdisciplinary and translational marks.

What the Selectors Are Actually Looking For

The NSF selection committee isn't just seeking excellent science; they're looking for visionary leadership and transformative potential at the convergence of disciplines.

Beyond the stated requirements, they will prioritize proposals that demonstrate a truly *synergistic* and *integrative* approach, showcasing how the fusion of evolutionary and molecular biology, rather than their mere juxtaposition, creates novel insights and pathways for biotech.

The 'translation' aspect is paramount; applications must move beyond discovery to clearly articulate how findings will be applied in biotech, implying a strong understanding of the innovation pipeline.

Crucially, the 'leveraging emerging AI and computing' isn't a checkbox; selectors will be scrutinizing the sophistication, necessity, and novelty of these computational tools within your methodology, ensuring they are integral to achieving the project's bold goals.

They want high-risk, high-reward projects with significant potential for societal impact, backed by a credible, interdisciplinary team capable of executing such a complex, forward-looking vision.

Clear articulation of potential intellectual property and a robust plan for managing interdisciplinary collaboration will undoubtedly strengthen an application.

Key Facts

  • Opportunity Name: Leveraging Innovations From Evolution (LIFE)
  • Organization: National Science Foundation (NSF)
  • Type: Grant
  • Deadline: January 30, 2025
  • Funding Amount: $1,000,000 to $1,200,000
  • Eligible Regions: North America (specifically US-accredited IHEs)
  • Key Domains: Health, Tech, General (with specific focus on evolutionary/molecular biology and biotech)
  • Applicant Type: Researchers (submitted by Institutions of Higher Education)

Frequently Asked Questions

Is this opportunity open to private biotech companies or individual startups?

No, proposals must be submitted by Institutions of Higher Education (IHEs) accredited in the US, its territories, or Puerto Rico. Private companies or individual startups are not directly eligible to apply.

How critical is the AI and computing component to a successful proposal?

The description explicitly states 'leveraging emerging AI and computing' as a core aspect. Proposals without a robust, well-integrated, and demonstrably essential AI/computing strategy will likely be considered a poor fit.

Does the research need to have immediate commercialization potential?

While the program aims to 'translate biological innovations into biotech applications,' the focus is on foundational research that *leads* to these applications. A clear pathway to future translation is necessary, but immediate market readiness is not the primary requirement.

Can international institutions collaborate on a proposal?

Yes, but the lead institution submitting the proposal *must* be a US-accredited IHE with a campus in the US, its territories, or Puerto Rico. International collaborators cannot be the primary applicant.

What is meant by 'integrative research uniting evolutionary and molecular biology'?

This refers to projects that genuinely merge insights, methodologies, and perspectives from both evolutionary biology and molecular biology to create novel scientific approaches and outcomes, rather than simply having separate components from each field.

Startup911's Take

This NSF LIFE opportunity presents a high-value, high-visibility funding pathway for select academic teams at the forefront of biological innovation. At $1M-$1.2M, it's a substantial grant, but the competitiveness will be fierce given the specific, interdisciplinary requirements and the broad 'general' domain.

The January 2025 deadline provides ample time for strategic team formation and meticulous proposal development, which will be crucial. Our advice: do not underestimate the 'integrative' and 'translational' aspects.

Form genuinely interdisciplinary teams that bridge evolutionary biologists, molecular biologists, and AI/computational scientists from the outset. Focus your narrative on the *synergy* between these fields, clearly outlining the novel biotech applications and the specific, indispensable role of AI in accelerating discovery or development.

IP potential, while not the sole focus, should be a strong, though not exclusive, consideration. This is a strategic play for institutions looking to establish leadership in the convergence of fundamental biology, AI, and biotech translation.

Get Personalized Opportunities Delivered to Your Inbox

Join Startup911 newsletter and receive opportunities matched to your profile, location, and startup stage.

Subscribe to Newsletter